Dimitris Voliotis - SVP, Clinical Development at Zentalis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Clinical Development
Stock Symbol
ZNTL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Dimitris Voliotis since 9/17/2023

Holdings reported by Dimitris Voliotis for Zentalis Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 24.2K $1.16M $47.80 Feb 10, 2022 Direct Common Stock
Common Stock 16K $164K $10.29 Feb 14, 2022 Direct

Transactions reported by Dimitris Voliotis for Zentalis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.